Spain leads world in benzodiazepine use as hidden malaise grows

Spain leads global benzodiazepine consumption: the link to the job market and urban life

A report by the International Narcotics Control Board ranks Spain as the world's largest consumer of benzodiazepines and psychotropic drugs. The figure comes as no surprise to those who track the evolution of the job market, the degradation of public spaces and the loss of life prospects. Data from the Spanish Agency for Medicines confirm that more than 1.5 million people take anxiolytics daily, and pharmaceutical spending on this category exceeds 200 million euros a year. The question is whether medication treats the symptom or numbs a structural malaise that no one wants to diagnose.

Precarious work and exhaustive control: the anxiety factory

The official narrative insists on economic recovery, but mental health indicators paint a different picture. According to data from the INE (National Statistics Institute) and the Ministry of Health, 80% of salaried workers report job dissatisfaction. Conditions have worsened: timers on cashiers, software that detects mouse movement in offices and GPS in delivery vehicles. Demands grow while wages stagnate and internal promotion disappears. It is no coincidence that benzodiazepine consumption is concentrated in the 30-55 age group, precisely those bearing the double pressure of a mortgage and precarious work. A revealing fact: 90% of calls to the suicide prevention hotline (more than 90,000 in the first year) were based on financial or work problems, according to service sources.

Noise, overcrowding and lack of nature: the city as a risk factor

The Spanish urban environment combines particularly adverse conditions. Dense traffic, constant construction, terraces and nightlife extend into the early hours, preventing rest. A study by the University of Barcelona links exposure to nighttime noise with a 12% increase in the use of hypnotics. In addition, the housing model—small, poorly insulated flats with little greenery—contrasts with that of northern European countries, where single-family homes with gardens are the majority in the outskirts. The absence of accessible green spaces exacerbates the feeling of confinement. A comparative analysis between Spanish and Dutch cities shows that even in working-class neighborhoods in the Netherlands, density is lower and tree presence is higher.

Easy prescription, guaranteed dependence

The public health system contributes to the problem with a lax prescribing policy. Visiting a GP with symptoms of anxiety or insomnia often ends with a prescription for benzodiazepines, which cost the patient less than one euro. Pensioners do not even pay that amount. Pharmaceutical companies have a clear incentive: maintaining a steady flow of consumers. Doctors, for their part, find in prescribing the quickest solution to avoid conflict and reduce care pressure. However, abuse of these drugs is not harmless: they alter brain structure, create dependence and abrupt withdrawal can cause serious effects. Despite this, there are hardly any awareness campaigns about the risks.

The loss of purpose: when happiness becomes an obligation

Behind the figures lies a cultural phenomenon: Spanish society has replaced the meaning of life with the hedonistic pursuit of happiness, an unattainable goal that generates more frustration. Previously, collective projects and acceptance of life's harshness offered a framework for resilience. Now, the dominant discourse promises immediate satisfaction, and when reality fails to provide it, the individual feels like a failure and turns to pharmacology. Cocaine use in work environments, mentioned as an epidemic in certain sectors, is the other side of this medicalization of daily life. Spain not only leads in benzodiazepine consumption: it also stands out in illegal stimulants, pointing to the same malaise being tackled with chemicals instead of structural changes.

In short, Spain's lead in psychotropic drugs is not a statistical anomaly but the reflection of an economic and social model that generates anxiety and treats it with cheap pills. Until the causes—precarious work, inadequate housing, chronic noise and lack of life projects—are addressed, prescriptions will remain the patch for a system that anesthetizes its population instead of curing it.